Lansoprazol Flas Viatris (Lansoprazole)

Lansoprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This inhibition prevents the final step of acid production, leading to a sustained decrease in both basal and stimulated gastric acid secretion, thereby creating a less acidic gastric environment.

The appropriate dose of Lansoprazol Flas Viatris is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Lansoprazole is classified as pregnancy Category B, indicating that animal studies have not shown risk to the fetus and there are no adequate human studies. It may be used during pregnancy if the potential benefit justifies the risk. Limited data are available for breastfeeding, so a clinician should evaluate the risk‑benefit ratio.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lansoprazole and other PPIs like omeprazole share the same mechanism of inhibiting the gastric proton pump, but they differ in pharmacokinetic profiles, onset of action and drug‑interaction potential. Lansoprazole may have a slightly longer half‑life and is often preferred when a patient experiences suboptimal response or specific drug‑interaction concerns with other PPIs.

Lansoprazol Flas Viatris should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

The medication is taken orally, usually as a whole tablet or capsule swallowed with water. It is generally recommended to take the dose before a meal, often in the morning, unless the prescriber advises a different schedule based on the individual treatment plan.

Serious but rare risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, liver enzyme elevations, Stevens‑Johnson syndrome, interstitial nephritis and low magnesium levels that can cause muscle weakness or cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms like rash, persistent diarrhea, jaundice or muscle cramps.

Individuals with known hypersensitivity to lansoprazole or any component of the formulation should not use the product. Caution is also advised for patients with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of C. difficile infection or low magnesium levels.